Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain

Rui Zhang1, Zhenying Han1, Vincent Degos1,2

  • 1Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA, USA.

Angiogenesis
|June 22, 2016
PubMed

Insights

Macrophage accumulation in brain arteriovenous malformations (bAVM) is driven by persistent monocyte infiltration and inflammation. Targeting macrophage homing may reduce bAVM severity.

Area of Science:

  • Vascular Biology
  • Immunology
  • Genetics

Background:

  • Brain arteriovenous malformations (bAVM) exhibit high macrophage counts, linked to inflammation and vascular remodeling.
  • The underlying causes of macrophage accumulation in bAVM remain unclear.

Purpose of the Study:

  • To investigate if persistent monocyte infiltration and pro-inflammatory differentiation contribute to increased macrophages in bAVM.
  • To test the hypothesis using mouse models and human monocyte studies.

Main Methods:

  • Induced bAVM in Endoglin (Eng) and Alk1 gene-deleted mice with angiogenic stimulation.
  • Co-cultured endothelial and smooth muscle cells with monocytes to study differentiation.
  • Analyzed macrophage/microglia populations and bone marrow-derived macrophages in mouse models.
  • Compared macrophage differentiation from peripheral blood cells of patients with ENG/ALK1 mutations versus healthy controls.

Main Results:

  • Eng-deleted mice showed increased macrophages in the brain angiogenic region by 8 weeks post-stimulation.
  • Alk1-deficient mice exhibited a trend towards more macrophages and significantly more bone marrow-derived macrophages.
  • CD34(+) cells from patients with ENG or ALK1 mutations differentiated into macrophages more readily than those from controls.

Conclusions:

  • Persistent monocyte infiltration and pro-inflammatory differentiation likely contribute to macrophage burden in bAVM.
  • Blocking macrophage homing to bAVM lesions presents a potential therapeutic strategy to mitigate disease severity.